Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 3:10 pm Purchase | 13G | Longboard Pharmaceuticals Inc. LBPH | Cormorant Asset Management LP | 2,790,462 8.100% | 648,956 (+30.30%) | View |
| 2024-11-14 1:22 pm Purchase | 13G | Longboard Pharmaceuticals Inc. LBPH | PRICE T ROWE ASSOCIATES INC | 2,909,257 7.500% | 1,282,275 (+78.81%) | View |
| 2024-11-12 3:59 pm Unchanged | 13G | Longboard Pharmaceuticals Inc. LBPH | VANGUARD GROUP INC | 2,033,068 5.220% | 0 (Unchanged) | View |
| 2024-11-08 5:15 pm Purchase | 13G | Longboard Pharmaceuticals Inc. LBPH | Farallon Capital Partners L.P. | 3,456,063 9.990% | 1,250,073 (+56.67%) | View |
| 2024-11-08 2:17 pm Unchanged | 13G | Longboard Pharmaceuticals Inc. LBPH | BlackRock Inc. BLK | 2,837,880 8.300% | 0 (Unchanged) | View |
| 2024-11-07 09:26 am Sale | 13G | Longboard Pharmaceuticals Inc. LBPH | FMR LLC | 545,108 1.401% | -3,804,991 (-87.47%) | View |
| 2024-11-07 09:12 am Sale | 13G | Longboard Pharmaceuticals Inc. LBPH | FMR LLC | 4,350,099 11.182% | -156,368 (-3.47%) | View |
| 2024-11-04 1:25 pm Purchase | 13G | Longboard Pharmaceuticals Inc. LBPH | VANGUARD GROUP INC | 2,033,068 5.220% | 2,033,068 (New Position) | View |
| 2024-10-22 3:24 pm Purchase | 13G | Longboard Pharmaceuticals Inc. LBPH | BlackRock Inc. BLK | 2,837,880 8.300% | 2,837,880 (New Position) | View |
| 2024-07-15 4:17 pm Purchase | 13G | Longboard Pharmaceuticals Inc. LBPH | VIKING GLOBAL INVESTORS LP | 1,752,656 5.200% | 1,752,656 (New Position) | View |
| 2024-03-11 08:19 am Purchase | 13G | Longboard Pharmaceuticals Inc. LBPH | FMR LLC | 4,506,467 12.749% | 2,856,964 (+173.20%) | View |
| 2024-02-14 3:04 pm Purchase | 13G | Longboard Pharmaceuticals Inc. LBPH | Cormorant Asset Management LP | 2,141,506 9.990% | 339,559 (+18.84%) | View |
| 2024-02-14 10:03 am Purchase | 13G | Longboard Pharmaceuticals Inc. LBPH | PRICE T ROWE ASSOCIATES INC | 1,626,982 7.600% | 116,021 (+7.68%) | View |
| 2024-02-14 06:03 am Sale | 13G | Longboard Pharmaceuticals Inc. LBPH | Point72 Asset Management L.P. | 825,000 3.800% | -425,000 (-34.00%) | View |
| 2024-02-13 4:07 pm Sale | 13G | Longboard Pharmaceuticals Inc. LBPH | HBM Healthcare Investments (Cayman) Ltd. | 0 0.000% | -1,345,009 (Position Closed) | View |
| 2024-02-13 09:55 am Sale | 13G | Longboard Pharmaceuticals Inc. LBPH | Prosight Management LP | 0 0.000% | -948,012 (Position Closed) | View |
| 2024-02-09 09:16 am Sale | 13G | Longboard Pharmaceuticals Inc. LBPH | FMR LLC | 1,649,503 7.694% | -297,813 (-15.29%) | View |
| 2024-01-30 11:23 am Purchase | 13G | Longboard Pharmaceuticals Inc. LBPH | Farallon Capital Partners L.P. | 2,205,990 9.990% | 788,073 (+55.58%) | View |
| 2024-01-29 5:01 pm Sale | 13D | Longboard Pharmaceuticals Inc. LBPH | PFIZER INC PFE | 0 0.000% | -3,978,540 (Position Closed) | View |
| 2024-01-26 4:19 pm Sale | 13G | Longboard Pharmaceuticals Inc. LBPH | INTEGRATED CORE STRATEGIES (US) LLC | 6,610 0.000% | -981,102 (-99.33%) | View |